Diseases of biliary tract in the context of association with oncological diseases of the digestive system


Cite item

Full Text

Abstract

Cancers of the gastrointestinal tract are widespread among the population and cause significant damage to the health care system. In order to improve the strategy of preventive measures and the detection of oncological diseases at the early stages, it is necessary to provide timely impact on possible risk factors contributing to the onset and progression of malignant neoplasms. This review demonstrates the association between the pathology of the biliary tract and oncological diseases of the digestive system, discusses the possible mechanisms of the influence of cholelithiasis and cholecystectomy on the development of malignant neoplasms of various parts of the gastrointestinal tract.

About the authors

M A Osadchuk

Sechenov First Moscow State Medical University (Sechenov University)

Moscow, Russia

A A Svistunov

Sechenov First Moscow State Medical University (Sechenov University)

Moscow, Russia

E D Mironova

Sechenov First Moscow State Medical University (Sechenov University)

Moscow, Russia

I N Vasil’eva

Sechenov First Moscow State Medical University (Sechenov University)

Moscow, Russia

N V Kireeva

Sechenov First Moscow State Medical University (Sechenov University)

Moscow, Russia

References

  1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11-30. doi: 10.3322/caac.21166
  2. Каприн А.Д., Старинский В.В., Петрова Г.В., ред. Злокачественные новообразования в России в 2017 году (заболеваемость и смертность). М.: МНИОИ им. П.А. Герцена Филиал ФГБУ «НМИЦ Радиологии» Минздрава России, 2018.
  3. Jemal A, Bray F, Center M.M, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69-90. doi: 10.3322/caac.20107
  4. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359-386. doi: 10.1002/ijc.29210
  5. Portincasa P, Moschetta A, Palasciano G. Cholesterol gallstone disease. Lancet. 2006;368(9531):230-9. doi: 10.1016/S0140-6736(06)69044-2
  6. Everhart J.E, Ruhl C.E. Burden of digestive diseases in the United States part I: overall and upper gastrointestinal diseases. Gastroenterology. 2009;136(2):376-86. doi: 10.1053/j.gastro.2008.12.015
  7. Farthing M, Roberts.SE, Samuel D.G, et al. Survey of digestive health across Europe: Final report. Part 1: The burden of gastrointestinal diseases and the organisation and delivery of gastroenterology services across Europe. United European Gastroenterol J. 2014;2(6):539-43. doi: 10.1177/2050640614554154
  8. Rodriguez S, Gaunt T.R, Guo Y, et al. Lipids, obesity and gallbladder disease in women: insights from genetic studies using the cardiovascular genecentric 50K SNP array. Eur J Hum Genet. 2016;24(1):106-12. doi: 10.1038/ejhg.2015.63
  9. Fukuma H, Morshed S.A, Watanabe S, et al. Increased expression of cytokines in liver and serum in patients with extrahepatic diseases. J Gastroenterol. 1996;31(4):538-45.
  10. Chiba T, Marusawa H, Ushijima T. Inflammation - associated cancer development in digestive organs: mechanisms and roles for genetic and epigenetic modulation. Gastroenterology. 2012;143(3):550-63. doi: 10.1053/j.gastro.2012.07.009
  11. Grivennikov S.I, Greten F.R, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140(6):883-99. doi: 10.1016/j.cell.2010.01.025
  12. Abbas T, Keaton M.A, Dutta A. Genomic instability in cancer. Cold Spring Harb Perspect Biol. 2013;5(3):a012914. doi: 10.1101/cshperspect.a012914
  13. Allavena P, Sica A, Solinas G, Porta C, Mantovani A. The inflammatory micro - environment in tumor progression: the role of tumor - associated macrophages. Crit Rev Oncol Hematol. 2008;66(1):1-9. doi: 10.1016/j.critrevonc.2007.07.004
  14. Zang J, Yuan Y, Zhang C, Gao J. Elective laparoscopic cholecystectomy without intraoperative cholangiography: role of preoperative magnetic resonance cholangiopancreatography - a retrospective cohort study. BMC Surg. 2016;16(1):45. doi: 10.1186/s12893-016-0159-9
  15. Holzheimer R.G, Mannick J.A, eds. Surgical Treatment: Evidence-Based and Problem-Oriented. Munich: Zuckschwerdt; 2001. Accessed July 03, 2019. http://www.ncbi.nlm.nih.gov/books/NBK6880/
  16. Mahid S.S, Jafri N.S, Brangers B.C, Minor K.S, Hornung C.A, Galandiuk S. Meta - analysis of cholecystectomy in symptomatic patients with positive hepatobiliary iminodiacetic acid scan results without gallstones. Arch Surg. 2009;144(2):180-7. doi: 10.1001/archsurg.2008.543
  17. Sonne D.P, Hare K.J, Martens P, et al. Postprandial gut hormone responses and glucose metabolism in cholecystectomized patients. Am J Physiol Gastrointest Liver Physiol. 2013;304(4):G413-419. doi: 10.1152/ajpgi.00435.2012
  18. Russell D.W. The enzymes, regulation, and genetics of bile acid synthesis. Annu Rev Biochem. 2003;72:137-74. doi: 10.1146/ annurev.biochem.72.121801.161712
  19. Hofmann A.F. The continuing importance of bile acids in liver and intestinal disease. Arch Intern Med. 1999;159(22):2647-58.
  20. Chiang J.Y.L. Bile acids: regulation of synthesis. J Lipid Res. 2009;50(10):1955-66. doi: 10.1194/jlr.R900010-JLR200
  21. Russell D.W, Setchell K.D. Bile acid biosynthesis. Biochemistry. 1992;31(20):4737-49.
  22. Ridlon J.M, Kang D-J, Hylemon P.B. Bile salt biotransformations by human intestinal bacteria. J Lipid Res. 2006;47(2):241-59. doi: 10.1194/jlr.R500013-JLR200
  23. Chiang J.Y.L. Bile Acid Metabolism and Signaling. Compr Physiol. 2013;3(3):1191-212. doi: 10.1002/cphy.c120023
  24. Di Ciaula A, Garruti G, Lunardi Baccetto R, et al. Bile Acid Physiology. Ann Hepatol. 2017;16:S4-S14. doi: 10.5604/01.3001.0010.5493
  25. Staley C, Weingarden A.R, Khoruts A, Sadowsky M.J. Interaction of Gut Microbiota with Bile Acid Metabolism and its Influence on Disease States. Appl Microbiol Biotechnol. 2017;101(1):47-64. doi: 10.1007/s00253-016-8006-6
  26. Chen Y-K, Yeh J-H, Lin C-L, et al. Cancer risk in patients with cholelithiasis and after cholecystectomy: a nationwide cohort study. J Gastroenterol. 2014;49(5):923-31. doi: 10.1007/s00535-013-0846-6
  27. Bernstein C, Holubec H, Bhattacharyya A.K, et al. Carcinogenicity of deoxycholate, a secondary bile acid. Arch Toxicol. 2011;85(8):863-71. doi: 10.1007/s00204-011-0648-7
  28. Reddy B.S, Wynder E.L. Metabolic epidemiology of colon cancer. Fecal bile acids and neutral sterols in colon cancer patients and patients with adenomatous polyps. Cancer. 1977;39(6):2533-9.
  29. Huo X, Juergens S, Zhang X, et al. Deoxycholic acid causes DNA damage while inducing apoptotic resistance through NF-κB activation in benign Barrett’s epithelial cells. Am J Physiol Gastrointest Liver Physiol. 2011;301(2):G278-286. doi: 10.1152/ajpgi.00092.2011
  30. Wang X, Sun L, Wang X, et al. Acidified bile acids enhance tumor progression and telomerase activity of gastric cancer in mice dependent on c- Myc expression. Cancer Med. 2017;6(4):788-97. doi: 10.1002/cam4.999
  31. Nagathihalli N.S, Beesetty Y, Lee W, et al. Novel mechanistic in - sights into ectodomain shedding of EGFR Ligands Amphiregulin and TGF-α: impact on gastrointestinal cancers driven by secondary bile acids. Cancer Res. 2014;74(7):2062-72. doi: 10.1158/0008-5472.CAN-13-2329
  32. Quante M, Bhagat G, Abrams J.A, et al. Bile acid and inflammation activate gastric cardia stem cells in a mouse model of Barrett - like metaplasia. Cancer Cell. 2012;21(1):36-51. doi: 10.1016/j.ccr.2011.12.004
  33. Fitzgerald R.C, Abdalla S, Onwuegbusi B.A, et al. Inflammatory gradient in Barrett’s oesophagus: implications for disease complications. Gut. 2002;51(3):316-22.
  34. Attili A.F, Angelico M, Cantafora A, Alvaro D, Capocaccia L. Bile acid - induced liver toxicity: relation to the hydrophobic - hydrophilic balance of bile acids. Med Hypotheses. 1986;19(1):57-69.
  35. Tucker O.N, Dannenberg A.J, Yang E.K, Fahey T.J. Bile acids induce cyclooxygenase-2 expression in human pancreatic cancer cell lines. Carcinogenesis. 2004;25(3):419-23. doi: 10.1093/carcin/bgh010
  36. Koga S, Kaibara N, Takeda R. Effect of bile acids on 1,2-dimethylhydrazine - induced colon cancer in rats. Cancer. 1982;50(3):543-7.
  37. Zuccato E, Venturi M, Di Leo G, et al. Role of bile acids and metabolic activity of colonic bacteria in increased risk of colon cancer after cholecystectomy. Dig Dis Sci. 1993;38(3):514-9.
  38. Perez M-J, Briz O. Bile - acid - induced cell injury and protection. World J Gastroenterol. 2009;15(14):1677-89. doi: 10.3748/wjg.15.1677
  39. Lagergren J, Mattsson F. Cholecystectomy as a risk factor for oesophageal adenocarcinoma. Br J Surg. 2011;98(8):1133-7. doi: 10.1002/bjs.7504
  40. Freedman J, Ye W, Näslund E, Lagergren J. Association between cholecystectomy and adenocarcinoma of the esophagus. Gastroenterology. 2001;121(3):548-53.
  41. Ge Z, Zhao C, Wang Y, Qian J. Cholecystectomy and the risk of esophageal and gastric cancer. Saudi Med J. 2012;33(10):1073-9.
  42. Огнерубов Н.А. Желчнокаменная болезнь после хирургического лечения рака желудка: оправдана ли профилактическая холецистэктомия? Вестник ТГУ. 2017;22(1):148-54. doi: 10.20310/1810-0198-2017-22-1-148-154
  43. Inoue K, Fuchigami A, Higashide S, et al. Gallbladder sludge and stone formation in relation to contractile function after gastrectomy. A prospective study. Ann Surg. 1992;215(1):19-26.
  44. Hauters P.P, de Neve de Roden A, Pourbaix A, Aupaix F, Coumans P, Therasse G. Cholelithiasis: a serious complication after total gastrectomy. Br J Surg. 1988;75:899-900.
  45. Kobayashi T, Hisanaga M, Kanehiro H, Yamada Y, Ko S, Nakajima Y. Analysis of risks factors for the development of gallstones after gastrectomy. Br J Surg.2005;92:1399-403. doi: 10.1002/bjs.5117
  46. Ichimiya H, Kono S, Ikeda M, Tokudome S, Nakayama F, Kuratsune M. Cancer mortality among patients undergoing cholecystectomy for benign biliary diseases. Jpn J Cancer Res. 1986;77(6):579-83.
  47. Freedman J, Lagergren J, Bergström R, Näslund E, Nyrén O. Cholecystectomy, peptic ulcer disease and the risk of adenocarcinoma of the oesophagus and gastric cardia. Br J Surg. 2000;87(8):1087-93. doi: 10.1046/j.1365-2168.2000.01459.x
  48. Kalima T, Sjöberg J. Bile reflux after cholecystectomy. Scand J Gastroenterol Suppl. 1981;67:153-6.
  49. Kang S.H, Kim Y.H, Roh Y.H, et al. Gallstone, cholecystectomy and risk of gastric cancer. Ann Hepatobiliary Pancreat Surg. 2017;21(3):131-7. doi: 10.14701/ahbps.2017.21.3.131
  50. Nogueira L, Freedman N.D, Engels E.A, Warren J.L, Castro F, Koshiol J. Gallstones, cholecystectomy, and risk of digestive system cancers. Am J Epidemiol. 2014;179(6):731-9. doi: 10.1093/aje/kwt322
  51. Hardt P.D, Bretz L, Krauss A, et al. Pathological pancreatic exocrine function and duct morphology in patients with cholelithiasis. Dig Dis Sci. 2001;46(3):536-9.
  52. Gong Y, Li S, Tang Y, et al. Cholelithiasis and risk of pancreatic cancer: systematic review and meta - analysis of 21 observational studies. Cancer Causes Control. 2014;25(11):1543-51. doi: 10.1007/s10552-014-0458-3
  53. Hyvärinen H, Partanen S. Association of cholecystectomy with abdominal cancers. Hepatogastroenterology. 1987;34(6):280-4.
  54. Smith J.P, Solomon T.E, Bagheri S, Kramer S. Cholecystokinin stimulates growth of human pancreatic adenocarcinoma SW-1990. Dig Dis Sci. 1990;35(11):1377-84.
  55. Palmer W.C, Patel T. Are common factors involved in the pathogenesis of primary liver cancers? A meta - analysis of risk factors for intrahepatic cholangiocarcinoma. J Hepatol. 2012;57(1):69-76. doi: 10.1016/j. jhep.2012.02.022
  56. Ioannou G.N. Cholelithiasis, cholecystectomy, and liver disease. Am J Gastroenterol. 2010;105(6):1364-73. doi: 10.1038/ajg.2009.737
  57. Guo L, Mao J, Li Y, et al. Cholelithiasis, cholecystectomy and risk of hepatocellular carcinoma: a meta - analysis. J Cancer Res Ther. 2014;10(4):834-8. doi: 10.4103/0973-1482.135992
  58. Wang Y, Xie L-F, Lin J. Gallstones and cholecystectomy in relation to risk of liver cancer. Eur J Cancer Prev. 2019;28(2):61-7. doi: 10.1097/CEJ.0000000000000421
  59. Liu Y, He Y, Li T, et al. Risk of primary liver cancer associated with gallstones and cholecystectomy: a meta - analysis. PLoS ONE. 2014;9(10):e109733. doi: 10.1371/journal.pone.0109733
  60. Xiong J, Wang Y, Huang H, et al. Systematic review and meta - analysis: cholecystectomy and the risk of cholangiocarcinoma. Oncotarget. 2017;8(35):59648-57. doi: 10.18632/oncotarget.19570
  61. Medavaram S, Zhang Y. Emerging therapies in advanced hepatocellular carcinoma. Exp Hematol Oncol. 2018;7. doi: 10.1186/s40164-018-0109-6
  62. Siegel R.L, Miller K.D, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7-30. doi: 10.3322/caac.21442
  63. Dimitroulis D, Damaskos C, Valsami S, et al. From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world. World J Gastroenterol. 2017;23(29):5282-94. doi: 10.3748/wjg.v23.i29.5282
  64. El-Serag H.B. Hepatocellular carcinoma. N Engl J Med. 2011;365(12):1118-27. doi: 10.1056/NEJMra1001683
  65. Johansen C, Chow W.H, Jørgensen T, Mellemkjaer L, Engholm G, Olsen J.H. Risk of colorectal cancer and other cancers in patients with gall stones. Gut. 1996;39(3):439-43. doi: 10.1136/gut.39.3.439
  66. Tavani A, Rosato V, Di Palma F, et al. History of cholelithiasis and cancer risk in a network of case - control studies. Ann Oncol. 2012;23(8):2173-8. doi: 10.1093/annonc/mdr581
  67. Deschner E.E, Cohen B.I, Raicht R.F. Acute and chronic effect of dietary cholic acid on colonic epithelial cell proliferation. Digestion. 1981;21(6):290-6. doi: 10.1159/000198579
  68. Cohen B.I, Raicht R.F, Deschner E.E, Takahashi M, Sarwal A.N, Fazzini E. Effect of cholic acid feeding on N-methyl-N-nitrosourea - induced colon tumors and cell kinetics in rats. J Natl Cancer Inst. 1980;64(3):573-8.
  69. Pomare E.W, Heaton K.W. The effect of cholecystectomy on bile salt metabolism. Gut. 1973;14(10):753-62.
  70. El Zoghbi M, Cummings L.C. New era of colorectal cancer screening. World J Gastrointest Endosc. 2016;8(5):252-8. doi: 10.4253/wjge.v8.i5.252
  71. Berkhout M, Roelofs H.M.J, Friederich P, et al. Ursodeoxycholic acid intervention in patients with familial adenomatous polyposis: a pilot study. Transl Res. 2007;150(3):147-9. doi: 10.1016/j.trsl.2007.03.009
  72. Zhao M-F, Huang P, Ge C-L, Sun T, Ma Z-G, Ye F-F. Conjugated bile acids in gallbladder bile and serum as potential biomarkers for cholesterol polyps and adenomatous polyps. Int J Biol Markers. 2016;31(1):e73-79. doi: 10.5301/jbm.5000173
  73. Cheng K, Metry M, Felton J, Shang A.C, Drachenberg C.B, Xu S, Zhan M, Schumacher J, Guo G.L, Polli J.E, Raufman J.P. Diminished gallbladder filling, increased fecal bile acids, and promotion of colon epithelial cell proliferation and neoplasia in fibroblast growth factor 15-deficient mice. Oncotarget. 2018;9(39):25572-85.
  74. Flynn C, Montrose D.C, Swank D.L, Nakanishi M, Ilsley J.N, Rosenberg D.W. Deoxycholic acid promotes the growth of colonic aberrant crypt foci. Mol Carcinog. 2007;46(1):60-70. doi: 10.1002/mc.20253
  75. Raufman J.P, Dawson P.A, Rao A, Drachenberg C.B, Heath J, Shang A.C, Hu S, Zhan M, Polli J.E, Cheng K. Slc10a2-null mice uncover colon cancer - promoting actions of endogenous fecal bile acids. Carcinogenesis. 2015;36(10):1193-200. doi: 10.1093/carcin/bgv107
  76. Wang W, Wang J, Li J, et al. Cholecystectomy Damages Aging-Associated Intestinal Microbiota Construction. Front Microbiol. 2018;9. doi: 10.3389/fmicb.2018.01402
  77. Galitskiy M, Khomeriki S, Nikiforov P. Expression of proliferation and apoptosis markers in neoplasms of colon mucosa after cholecystectomy. Eksp Klin Gastroenterol. 2009;(5):28-32.
  78. Zhang Y, Liu H, Li L, et al. Cholecystectomy can increase the risk of colorectal cancer: A meta - analysis of 10 cohort studies. PLoS ONE. 2017;12(8):e0181852. doi: 10.1371/journal.pone.0181852
  79. Giovannucci E, Colditz G.A, Stampfer M.J. A meta - analysis of cholecystectomy and risk of colorectal cancer. Gastroenterology. 1993;105(1):130-41.
  80. Xu Y-K, Zhang F-L, Feng T, Li J, Wang Y-H. [Meta - analysis on the correlation of cholecystectomy or cholecystolithiasis to risk of colorectal cancer in Chinese population]. Ai Zheng. 2009;28(7):749-55.
  81. Chiong C, Cox M.R, Eslick G.D. Gallstone disease is associated with rectal cancer: a meta - analysis. Scand J Gastroenterol. 2012;47(5):553-64. doi: 10.3109/00365521.2012.660538
  82. Chiong C, Cox M.R, Eslick G.D. Gallstones are associated with colonic adenoma: a meta - analysis. World J Surg. 2012;36(9):2202-9. doi: 10.1007/s00268-012-1646-5

Copyright (c) 2019 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies